Open AccessIntegrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis
Author(s) -
Annalisa Sgoifo,
Angelo Bignamini,
L. La Mantia,
Maria Grazia Celani,
Piero Parietti,
Maria A. Ceriani,
Maria Raffaella Marazzi,
Paola Proserpio,
Lino Nobili,
Alessandra Protti,
Elio Agostoni
Publication year - 2017
Publication title -
neurology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.296
H-Index - 19
eISSN - 2193-8253
pISSN - 2193-6536
DOI - 10.1007/s40120-017-0081-9
Subject(s) - medicine , randomized controlled trial , quality of life (healthcare) , physical therapy , multiple sclerosis , intervention (counseling) , insomnia , chronic fatigue , neurology , chronic fatigue syndrome , psychiatry , nursing
Fatigue is a frequent, disabling, and difficult to treat symptom in neurological disease and in other stress-related conditions; Integrated Imaginative Distention (IID) is a therapy combining muscular and imaginative relaxation, feasible also in disabled subjects; the DIMMI SI trial was planned to evaluate IID efficacy on fatigue.